EUVIMEDEUVIMED entdecken
Scoping Review

Economic evaluations of intraoperative parathyroid hormone in parathyroid surgery: A scoping review

Ankit Parmar, Phillip Staibano, Jackie Han, Michael Au, Feng Xie, Mohit Bhandari, J.E. Young, Han Zhang

McMaster University Medical Journal · 26.07.2026 · 22 (2) · 26

DOI: 10.15173/mumj.v22i2.4151 ↗

Kurz gefasst

Scoping Review in der Zeitschrift McMaster University Medical Journal, online erschienen am 26.07.2026. Verfasst von Ankit Parmar und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intraoperative PTH (IOPTH) is standard-of-care for minimally invasive parathyroidectomy when managing primary hyperparathyroidism (PHPT). Controversy persists in determining the value and cost-effectiveness of IOPTH in parathyroid surgery.

Objective

To evaluate the quality of economic evaluations of IOPTH in parathyroid surgery for PHPT.

Methods

A search was performed of the following databases: MEDLINE, EMBASE, EMCARE, and Scopus from January 1990 to January 2025. Screening and full-text review stages were performed in duplicate. We included studies that performed any economic analyses (e.g., cost analyses or descriptions, cost-effectiveness analyses, cost-benefit analyses) using IOPTH during surgery for parathyroid disease. We described study, disease, and economic analysis-specific questions. Risk of bias and methodological quality were evaluated in duplicate using ECOBIAS, CHEERS, and related tools.

Results

Of the 355 articles that underwent screening and full-text review, 22 articles met eligibility criteria. Most studies were published after 2005 (63.6%) and observational (77.3%). Most studies investigated PHPT (95.5%). Studies were primarily partial economic analyses (90.9%), such as cost analyses and descriptions, while few (9.1%) were full economic analyses (i.e., cost-effectiveness analyses). Direct costs were calculated with heterogeneous reporting of cost sourcing and no studies examined indirect costs. Most studies (90.9%) reported 50% or fewer economic methodological quality items, including study perspective, discounting, summary measures, and sensitivity analysis. Due to unstandardized reporting of outcomes, meta-analysis was not performed.

Conclusions

The debate underlying the economics of IOPTH is informed by poor quality studies that do not permit meta-analysis and fail to comprehensively evaluate the cost-effectiveness of IOPTH. These studies are primarily partial economic analyses and often fail to report critical economic elements including study perspective, short- and long-term costs, and sensitivity analyses. Better methods should be applied when evaluating the economics of technological adjuncts for parathyroid surgery.

Zitieren

APA

Parmar, A., Staibano, P., Han, J., Au, M., Xie, F., Bhandari, M., Young, J., & Zhang, H. (2026). Economic evaluations of intraoperative parathyroid hormone in parathyroid surgery: A scoping review. McMaster University Medical Journal, 22(2), 26. https://doi.org/10.15173/mumj.v22i2.4151

Vancouver

Parmar A, Staibano P, Han J, Au M, Xie F, Bhandari M, et al. Economic evaluations of intraoperative parathyroid hormone in parathyroid surgery: A scoping review. McMaster University Medical Journal. 2026;22(2):26. doi:10.15173/mumj.v22i2.4151

BibTeX
@article{Parmar2026,
  author = {Parmar, Ankit and Staibano, Phillip and Han, Jackie and Au, Michael and Xie, Feng and Bhandari, Mohit and Young, J.E. and Zhang, Han},
  title = {Economic evaluations of intraoperative parathyroid hormone in parathyroid surgery: A scoping review},
  journal = {McMaster University Medical Journal},
  year = {2026},
  volume = {22},
  number = {2},
  pages = {26},
  doi = {10.15173/mumj.v22i2.4151}
}
Kostenlos starten →